Recent Quotes (30 days)

You have no recent quotes
chg | %

Kitrinor Metals Inc  

(Public, CVE:SCYB)   Watch this stock  
Find more results for SCYB
4.07
-0.26 (-6.00%)
Oct 20 - Close
CVE data delayed by 15 mins - Disclaimer
Currency in CAD
Range 4.07 - 4.13
52 week 0.80 - 7.98
Open 4.13
Vol / Avg. 5,100.00/21,995.00
Mkt cap 21.40M
P/E     -
Div/yield     -
EPS -0.23
Shares 5.26M
Beta 25.67
Inst. own     -

Key stats and ratios

Q2 (Jun '17) 2016
Net profit margin - -
Operating margin - -
EBITD margin - -
Return on average assets -3034.54% -1300.90%
Return on average equity - -
CDP Score - -

Address

366 Bay St Suite 200
TORONTO, ON M5H 4B2
Canada
+1-416-3669192 (Phone)
+1-416-3612519 (Fax)

Website links

Description

Scythian Biosciences Corp, formerly Kitrinor Metals Inc, is a Canada-based pre-clinical research and development company. It is engaged in the process of developing drug therapies. The Company conducts a project regarding development of a cannabinoid-based combination drug therapy for the treatment of concussions and traumatic brain injury. The Company also provides a research in area of treatment of gastro-inflammatory disease.

Officers and directors

Lisa McCormack President, Chief Executive Officer, Director
Arvin Ramos Chief Financial Officer, Director
Maghsoud Dariani Chief Scientific Officer
Christopher O. Irwin Corporate Secretary
Age: 47
Patrick Mohan Director
Age: 55
James N. Fairbairn Independent Director
Age: 57